For condition: Alopecia
For condition: Alopecia Areata
Kid’s Alopecia Study (29 Weeks)
Study Summary
Who Can Participate?
Children aged 6 to less than 12 with severe Alopecia Areata may participate.
Inclusion Criteria
- have a diagnosis of AA with at least 50% scalp hair loss due to it
- have no evidence of terminal hair regrowth within the previous 12 months.
- Documented evidence of having received varicella vaccination (2 doses), OR evidence of prior exposure to VZV based on serological testing (i.e., a positive VZV IgG Ab result)
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating alopecia areata (8 visits)
- Will receive either an investigative oral treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- 29 weeks
For more information about this trial, please visit ClinicalTrials.gov
